Mikael Sunnåker

7PUBLICATIONS
15CO-AUTHORS
PharmacogenomicsMedical virologyNanotoxicology, health and safetyMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 08, 2026
Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor Mitiperstat.

|Oct 18, 2025
A Phase 2a Trial of Myeloperoxidase Inhibitor Mitiperstat in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis.

Javier Armisen, Armando Flor, John Eriksson

|Oct 14, 2025
No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration-QTc Modeling Assessment.

Mikael Sunnåker, Christian Källgren, Joanna Parkinson

|Apr 28, 2025
Population Pharmacokinetics of Osimertinib in Patients With Non-Small Cell Lung Cancer.

Martin Johnson, Yu-Wei Lin, Henning Schmidt

|Aug 12, 2024
The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat.

Chandrali S Bhattacharya, Patricia Ely Pizzato, Maria Heijer

|Jul 04, 2024
From Plan to Pivot: How Model-Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH Trials.

Anne-Kristina Mercier, Sebastian Ueckert, Mikael Sunnåker

Pageof 2

Frequent Collaborators

3 joint publications

Hans Ericsson

1 joint publications

Joanna Parkinson

1 joint publications

Jesper Sundell

1 joint publications

Dinko Rekić